Join the Narcan Injection group to help and get support from people like you.
Narcan Injection News (Page 2)
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder
FRIDAY, July 12, 2024 – Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28...
Trained Peers as Good as Social Workers at Preventing Opioid Overdoses
THURSDAY, July 11, 2024 – Support provided by someone who has personally lived with addiction is an effective way to follow-up with ER patients after an opioid overdose, new research shows. Patients...
New Drug Could Boost Lifesaving Powers of Overdose Drug Naloxone
MONDAY, July 8, 2024 – An experimental drug can supercharge the effects of the lifesaving overdose drug naloxone, potentially improving its effectiveness against new and more powerful opioids like...
FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....
FDA Medwatch Alert: Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter
ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe...